|
Recent Developments |
|
11-JUN-13
Elder Pharmaceuticals, one of leading pharmaceutical companies has clarified that as far as the company is aware, there is no proposal of the promoters to sell the shares in the company.
06-MAR-13
Elder Pharmaceuticals, one of leading pharmaceutical companies has agreed to establish a joint venture company with KOSE Corporation with the provisional name of KOSE Elder.
24-DEC-12
Elder Pharmaceuticals, one of the fastest growing Pharm... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 8118.74 | 9818.91 | 8314.30 | | Other Income | 165.42 | 84.89 | 84.28 | | Total Income | 8284.16 | 9903.80 | 8398.58 | | Cost of goods sold | 6423.34 | 7725.68 | 6606.26 | | OPBDIT | 1860.82 | 2178.12 | 1792.32 | | PAT | 685.20 | 856.42 | 714.01 | | Gross Block | - | - | - | | Equity capital | 205.37 | 205.37 | 205.37 | | EPS (Rs.) | - | 41.70 | 34.82 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 7.15 - 10.43 | 8.88 - 12.64 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 22.5 | 22.0 | 21.3 | | Net margin (% of OI) | 8.3 | 8.6 | 8.5 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
